125 related articles for article (PubMed ID: 23044956)
21. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.
Nudleman E; Witmer MT; Kiss S; Williams GA; Wolfe JD
Retina; 2014 Oct; 34(10):2128-32. PubMed ID: 24946102
[TBL] [Abstract][Full Text] [Related]
22. Morphologic findings in acute central serous chorioretinopathy using spectral domain-optical coherence tomography with simultaneous angiography.
Shinojima A; Hirose T; Mori R; Kawamura A; Yuzawa M
Retina; 2010 Feb; 30(2):193-202. PubMed ID: 20142712
[No Abstract] [Full Text] [Related]
23. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
Song IS; Shin YU; Lee BR
Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.
Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Bahcecioglu H
Curr Eye Res; 2010 Feb; 35(2):91-8. PubMed ID: 20136418
[TBL] [Abstract][Full Text] [Related]
25. [Photodynamic therapy in a patient with chronic central serous chorioretinopathy--a case report].
Pociej W; Karska-Basta I; Kolár L; Oleksy P; Romanowska-Dixon B
Klin Oczna; 2014; 116(1):28-31. PubMed ID: 25137918
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and therapeutic challenges.
Gupta OP; Garg SJ; Negrey JN; Jahnle R; Pasion R; Ip MS; Hwang FS; Kaines A; Jain AK; Schwartz SD
Retina; 2010 Jun; 30(6):975-80. PubMed ID: 20531147
[No Abstract] [Full Text] [Related]
27. Diagnostic and therapeutic challenges.
Ascaso FJ; Rojo M; Minguez E; Cohen SM; Yang SS
Retina; 2011 Mar; 31(3):616-22. PubMed ID: 21336073
[No Abstract] [Full Text] [Related]
28. Spectral domain optical coherence tomography and angiographic findings in central serous chorioretinopathy complicated by bilateral nonrhegmatogenous retinal detachment associated with systemic corticosteroids.
Arantes TE; Garcia CR; Rossi MR; Muccioli C
Ocul Immunol Inflamm; 2009; 17(5):316-8. PubMed ID: 19831561
[TBL] [Abstract][Full Text] [Related]
29. Early changes in foveal thickness in eyes with central serous chorioretinopathy.
Hata M; Oishi A; Shimozono M; Mandai M; Nishida A; Kurimoto Y
Retina; 2013 Feb; 33(2):296-301. PubMed ID: 23023530
[TBL] [Abstract][Full Text] [Related]
30. Does microperimetry have a prognostic value in central serous chorioretinopathy?
Roisman L; Ribeiro JC; Fechine FV; Lavinsky D; Moraes N; Campos M; Farah ME
Retina; 2014 Apr; 34(4):713-8. PubMed ID: 23975001
[TBL] [Abstract][Full Text] [Related]
31. Focal choroidal excavation in eyes with central serous chorioretinopathy.
Ellabban AA; Tsujikawa A; Ooto S; Yamashiro K; Oishi A; Nakata I; Miyake M; Akagi-Kurashige Y; Ueda-Arakawa N; Arichika S; Yoshitake S; Takahashi A; Yoshimura N
Am J Ophthalmol; 2013 Oct; 156(4):673-83. PubMed ID: 23831223
[TBL] [Abstract][Full Text] [Related]
32. Central serous chorioretinopathy after surgical repair of a blowout fracture.
Chang M; Baek S; Lee TS
J Craniofac Surg; 2012 Nov; 23(6):1923-4. PubMed ID: 23172445
[TBL] [Abstract][Full Text] [Related]
33. Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy.
Matsumoto H; Kishi S; Sato T; Mukai R
Am J Ophthalmol; 2011 Apr; 151(4):617-623.e1. PubMed ID: 21257153
[TBL] [Abstract][Full Text] [Related]
34. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
35. The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy.
Breukink MB; den Hollander AI; Keunen JE; Boon CJ; Hoyng CB
Acta Ophthalmol; 2014 Sep; 92(6):e488-90. PubMed ID: 24698599
[No Abstract] [Full Text] [Related]
36. [Preeclampsia and retinal complications].
Troumani Y; Touhami S; Beral L; David T
J Fr Ophtalmol; 2014 Dec; 37(10):834-5. PubMed ID: 25455553
[No Abstract] [Full Text] [Related]
37. Dark Spot in Fibrinous Central Serous Chorioretinopathy.
Singh SR; Dogra M; Dogra MR
JAMA Ophthalmol; 2018 Oct; 136(10):e182924. PubMed ID: 30326074
[No Abstract] [Full Text] [Related]
38. Oral rifampin for central serous retinopathy: a strategic approach in three patients.
Pouw AE; Olmos de Koo LC
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):98-102. PubMed ID: 25559520
[TBL] [Abstract][Full Text] [Related]
39. The expanded spectrum of focal choroidal excavation.
Margolis R; Mukkamala SK; Jampol LM; Spaide RF; Ober MD; Sorenson JA; Gentile RC; Miller JA; Sherman J; Freund KB
Arch Ophthalmol; 2011 Oct; 129(10):1320-5. PubMed ID: 21670327
[TBL] [Abstract][Full Text] [Related]
40. Choroidal vessel diameter in central serous chorioretinopathy.
Yang L; Jonas JB; Wei W
Acta Ophthalmol; 2013 Aug; 91(5):e358-62. PubMed ID: 23647989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
